PrEP, Male, Injectable Monitor (No HIV RNA)
Also known as: HIV, PrEP, Prophylaxis
Use
This profile aligns with current guidelines for monitoring male patients on injectable HIV PrEP.
Special Instructions
Not provided.
Limitations
HIV p24 antigen/antibody specimens with reactive results need further investigation with additional tests. Negative results do not preclude the possibility of exposure to or infection with HIV-1 and/or HIV-2. A false negative could occur if the marker's quantity is too low or if the marker is not present during the tested disease stage.
Methodology
Other
Biomarkers
LOINC Codes
- 56888-1 - HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
- 47236-5 - T palldm IgG+IgM SerPl Ql IA
- 43304-5 - C trach rRNA Spec Ql NAA+probe
- 43305-2 - N gonorrhoea rRNA Spec Ql NAA+probe
- 25835-0 - HIV1 RNA SerPl Ql NAA+probe
- 69353-1 - HIV 2 RNA SerPl Ql NAA+probe
- 80203-3 - HIV 1 & 2 Ab SerPlBld IA.rapid
- 85380-4 - HIV IA algorithm interp SerPlBld-Imp
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
4 mL
Minimum Volume
3 mL
Container
Gel-barrier tube
Collection Instructions
Usual blood collection technique.
Storage Instructions
Refrigerated up to 7 days
Causes for Rejection
Hemolysis; lipemia; received outside of specimen and/or storage and/or labeling requirements; aliquot received for HIV testing.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 days |
| Refrigerated | 7 days |
| Frozen | 6 weeks |
Other tests from different labs that may be relevant
